Skip to main content
SpringerLink
Log in

Avibactam/ceftazidime

Development of drug resistance: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Cano A, et al. Use of carbapenems in the combined treatment of emerging ceftazidime/avibactam-resistant and carbapenem-susceptible KPC-producing Klebsiella pneumoniae infections: Report of a case and review of the literature. Journal of Global Antimicrobial Resistance 22: 9-12, Sep 2020. Available from: URL: http://doi.org/10.1016/j.jgar.2019.11.007

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Avibactam/ceftazidime. Reactions Weekly 1812, 49 (2020). https://doi.org/10.1007/s40278-020-80528-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80528-9

Search

Navigation